Opioid Endocrinopathy: A Clinical Problem in Patients With Chronic Pain and Long-term Oral Opioid Treatment
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Background: The use of strong opioids for treatment of noncancer chronic pain has increased. However, strong evidence for sustained pain relief and improved function is lacking. Controversy prevails, whether hormonal changes are induced by long-term treatment with opioids. The purpose of this study was to investigate the occurrence of endocrine dysfunction in chronic pain patients on long-term opioid treatment. Methods: A study group of 39 chronic pain patients treated with strong oral opioids for more than 1 year was compared with a control group of 20 chronic pain patients without opioid treatment. Basic levels of prolactin and function of the hypothalamic-pituitary-thyroid-, hypothalamic-pituitary-adrenal-axis, and hypothalamic-pituitary-growth-hormone - and hypothalamic-pituitary-gonadal-axis were measured. Quality-of-life and side effects were estimated with EORTC-QLQ-C30. Results: In the opioid-treated group, the patients had signs of pituitary dysfunction affecting all axes. Significant differences were shown in hypofunction of the hypothalamic-pituitary-gonadal -axis, hyperfunction of the hypothalamic-pituitary-adrenal -axis, and higher prolactin levels in the opioid-treated group, compared with the control group. The degree of pain was rated the same in both groups, but the opioid-treated group reported more side effects and lower quality of life. Conclusions: Long-term treatment of chronic pain with strong opioids causes side effects that can be attributed to hormonal abnormalities caused by opioid-induced inhibition of hypothalamic-pituitary function. Hormone substitution can be indicated to treat symptoms. Decreasing the opioid dose or stopping the opioid treatment can reverse endocrine dysfunction. This needs to be recognized by all practitioners treating chronic pain patients with opioids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study evaluated 39 noncancer pain patients who received different oral opioids and 20 controls (118); GH stimulation test was not performed but mean serum IGF-I was lower in the opioid-treated group, although statistical significance was not attained.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
In the citing paper
“Variable results have also been described for the peripheral thyroid hormones; T4 levels were unaffected (74, 118, 136, 159, 160) or decreased (116, 160-162) and T3 levels were increased (74, 159) or unaffected (160) or decreased (161).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
In the citing paper
“Studies with dynamic thyrotropin-releasing hormone test performed in chronic opioid users have demonstrated conflicting results with enhanced (118), blunted (136, 155, 156), or no (74, 157) TSH response.”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
In the citing paper
“In a group of 39 noncancer pain patients on oral opioids, hyperprolactinemia was detected in approximately 40% of them (118).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [118]
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
Kalso, E., Edwards, J. E., Moore, A. R., & McQuay, H. J. (2004) · Pain · doi:10.1016/j.pain.2004.09.019 · Cited by 1,216 · cited 1×
“Number 39 20 Gender (M/F) 15/24 8/12 Mean age (range) 48 (32-63) 49 (32-63) Mean years with pain (range) 13 (4-30) 12 (4-23) Causes of pain”
Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases
Portenoy, R. K., & Foley, K. M. (1986) · Pain · doi:10.1016/0304-3959(86)90091-6 · Cited by 897
Equianalgesic Dose Ratios for Opioids
Pereira, J., Lawlor, P., Vigano, A., Dorgan, M., & Bruera, E. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00294-9 · Cited by 537
Critical issues on opioids in chronic non-cancer pain:
Eriksen, J., Sjøgren, P., Bruera, E., Ekholm, O., & Rasmussen, N. K. (2006) · Pain · doi:10.1016/j.pain.2006.06.009 · Cited by 515
Endocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial
Gimbel, J. S., Richards, P., & Portenoy, R. K. (2003) · Neurology · doi:10.1212/01.wnl.0000057720.36503.2c · Cited by 469
Chronic Pain in Canada ‐ Prevalence, Treatment, Impact and the Role of Opioid Analgesia
Moulin, D. E., Clark, A. J., Speechley, M., & Morley-Forster, P. K. (2002) · Pain Research and Management · doi:10.1155/2002/323085 · Cited by 443
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Cited by
Items 101–157 of 157
Olaya‐Contreras, P. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 3
Gadelha, M. R., Wildemberg, L. E., & Kasuki, L. (2022) · The Pituitary · doi:10.1016/b978-0-323-99899-4.00003-2 · Cited by 2
[Paracentesis in the treatment of ascites in cirrhotic patients].
Otaño, J., Sort, P., & Arroyo, V. (1999) · PubMed · Cited by 2
Opioids Use and Adrenal Insufficiency
Jung, J. H., Choi, Y. S., Kim, J. E., & Kim, E. (2014) · The Korean Journal of Hospice and Palliative Care · doi:10.14475/kjhpc.2014.17.3.113 · Cited by 2
Wirz, S., Schenk, M., & Kieselbach, K. (2022) · Der Schmerz · doi:10.1007/s00482-022-00655-9 · Cited by 2
Antiandrogene Wirkungen von Opioiden
Wirz, S. (2021) · Schmerzmedizin · doi:10.1007/s00940-021-3226-y · Cited by 2
Pregnancy Rates Among Women Treated with Medication for Opioid Use Disorder
Bello, J. K., Xu, K. Y., Salas, J., Bedrick, B. S., & Grucza, R. A. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08689-8 · Cited by 2
Opioids for Nonmalignant Chronic Pain
Woodbury, A. (2015) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2015.17.03.ecas1-1503 · Cited by 2
Rubino, D. (2011) · International Journal of General Medicine · doi:10.2147/ijgm.s23042 · Cited by 2
Hormone Testing and Treatment Enters Pain Care
Tennant, F. S. (2014) · Hospital Practice · doi:10.3810/hp.2014.12.1154 · Cited by 1
Neuroendocrinology of Female Reproduction
Wilkinson, M., & Imran, S. A. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108149938.004 · Cited by 1
THE LIVED EXPERIENCE OF 'OPIOID USE DISORDER' IN IRELAND IN THE 21ST CENTURY
Moran, L., Keenan, E., & Khalifa, E. (2019) · University of Limerick Institutional Repository (University of Limerick) · doi:10.13140/rg.2.2.23064.55047 · Cited by 1
Lumbar Degenerative Disk Disease: Workup and Conservative Treatment
Beckworth, W. J., Sodiq, D. K., Foster, L. G., & Sussman, W. I. (2015) · Springer eBooks · doi:10.1007/978-3-662-47756-4_15 · Cited by 1
The Role of Palliative Care in Lung Cancer
Davis, M. P., & Pennell, N. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52357-8.00058-5 · Cited by 1
Chai, D. B., Rosic, T., Bawor, M., & Samaan, Z. (2020) · Psychiatry International · doi:10.3390/psychiatryint1020008 · Cited by 1
Endocrinopathies and Their Recovery in a 20‐Year Cohort Study of People With Heroin Dependence
Tremonti, C., Twigg, S., Mills, K. L., Marel, C., Teesson, M., & Haber, P. (2026) · Clinical Endocrinology · doi:10.1111/cen.70109 · Cited by 1
Endocrine Manifestations of Addictive Diseases
Hallinan, R. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_123 · Cited by 1
Opioid-Induced Secondary Adrenal Insufficiency in a Young Patient with Chronic Pancreatitis
Majeed, A., Noverati, N., Kurian, C. J., & Jaggi, S. (2021) · The Medicine Forum · doi:10.29046/tmf.022.1.012 · Cited by 1
The Effects of Opioids on Female Reproductive Health Across the Life CoursePreprint
Corsi, D. J., & Murphy, M. S. Q. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/ujv7w · Cited by 1
Turner, S., Allen, V. M., Graves, L. E., Tanguay, R. L., Green, C. R., & Cook, J. L. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.05.013 · Cited by 1
Berrahal, I., Mâamri, A., Ayadi, B., Kissi, Y. E., & Haddad, M. (2018) · Sexologies · doi:10.1016/j.sexol.2018.10.001 · Cited by 1
The Issues Around Opioid Prescribing in HIV-Related Pain
Cox, S. (2013) · Pain Management · doi:10.2217/pmt.13.36 · Cited by 1
Understanding the Agent, Part II: Adverse Effects
McAnally, H. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-47497-7_3 · Cited by 1
Ravari, M. R., Sardoo, F. S., Tayari, Z., Soleimanisardoo, L., & Gozashti, M. H. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-022-01164-7 · Cited by 1
Stein, C. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch34 · Cited by 1
Network mechanism of opioids in treating abdominal pain caused by T-cell lymphoma
Li, X.-Y. (2024) · New medicine. · doi:10.61958/nmsg1394 · Cited by 1
Moussa, M., Tolba, N., Ashry, S., Ali, A. M. M., & Atallah, S. (2020) · Ain Shams Journal of Forensic Medicine and Clinical Toxicology · doi:10.21608/ajfm.2020.102261 · Cited by 1
Buprenorphine for Cancer Pain: Evidence, Guidelines, and Clinical Rationale for Early Use
Chwistek, M., Kinczewski, L., Buga, S., Agne, J. L., Moryl, N., Kandil, E. S., Gupta, M., Anițescu, M., Javed, S., Noonan, M., et al. (2026) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2025.7132 · Cited by 1
Cervicobrachialgia After Spinal Surgery
Breivik, H. (2014) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2014.972005 · Cited by 1
Effect of Opioids on Adrenal and Reproductive Endocrinology
Armeni, E., Grossman, A. B., & Khoo, B. C. E. (2022) · doi:10.1093/med/9780198870197.003.0211
Opioid-induced adrenal insufficiency: diagnosis and management
Donegan, D. M., & Bancos, I. (2026) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2026.2716201
Opioid induced hyperalgesia: A focus on opioid use in chronic pain
Cunningham, J. L. (2013) · Mental Health Clinician · doi:10.9740/mhc.n155462
The Relationship between Opioids Use, Cortisol and DHEAS
Jung, J. H., Choi, Y. S., Kim, S. M., Lee, J., Kim, E. H., Kim, J. E., Kim, E., Park, H., & Yoon, D. J. (2015) · The Korean Journal of Hospice and Palliative Care · doi:10.14475/kjhpc.2015.18.2.105
Prise en charge médicamenteuse des patients souffrant de douleur chronique réfractaire
Corriger, A. (2019) · theses.fr (ABES) · doi:10.70675/668e4777zf8d0z4bdcz9780z0f91fedfe2b6
(2011) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3283473351
Les complications systémiques du syndrome douloureux régional complexe
Schwartzman, R. J., & Grandjean, F. (2012)
Opioids and their endocrine effects: A systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Najafabadi, A. H. Z. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem/dgz022
Endocrinopathy in patients with cancer pain on opioids: prospective observational study
Mathur, A., Sharma, A., & Pavan Gaurav, R. (2026) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2025-006010
(2021) · The Medicine Forum · doi:10.29046/tmf.022.1
Nayema, Z., Spillane, J., Motyl, K. J., & Lary, C. W. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf168
Comps, O., Carrera, M.-J., Garcia, S., Moltó, L., & Montes, A. (2026) · European Journal of Anaesthesiology Intensive Care · doi:10.1097/ea9.0000000000000128
Stackelberg, L. (2014) · NORA - Norwegian Open Research Archives
Rojas, C. R. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Lukonina, T. D., Khoronenko, V. E., Abuzarova, G. R., Маланова, А., & Ageeva, A. A. (2024) · Regional Anesthesia and Acute Pain Management · doi:10.17816/ra636604
Codeine-Associated Secondary Adrenal Insufficiency: A Case Report
Varghese, E. A., Zachariah, N. T., & Zachariah, S. (2026) · Cureus · doi:10.7759/cureus.118882
Identification of Novel Causative Genes and Variants of Female Infertility
Yalcin, Z. (2024) · eScholarship@McGill (McGill) · doi:10.82308/5622
The Practice of Prescribing Opioids : Insights from Registries, Biomarkers, and Interviews
Kallman, T. F. (2025) · Linköping University medical dissertations · doi:10.3384/9789181181333
Serum hormone levels in women with chronic pain
Buck, L. (2019) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-bejkojom1
Hantoosh, M. F., Abedalla, S. A., & Urologist, A. A. (. (2026) · Neliti
Heroin-Induced Endocrinopathies in Female Addicts
Elkholy, M., Abdelnaby, A. Y., Seleem, M. A. H., & Gad, E.-S. A. H. (2025) · African Journal of Biomedical Research · doi:10.53555/ajbr.v28i2s.6863
When sex hurts: Female genital pain is no fun! Neither is painful sex in men
Finnerup, N. B., & Kirste, U. M. (2014) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2014.04.005
(2010) · Pharmaceutical Medicine · doi:10.1007/bf03256822
The substance-using woman and her sexual and reproductive health
Roy, P., & Chatterjee, J. (2021) · Indian Journal of Health, Sexuality and Culture · doi:10.5281/zenodo.5151888
Consequências das alterações imunológicas induzidas por opióides
Sousa, P. J. C. M. E. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Chronic pain management with complementary and alternative methods in surgical patienrs
Gantar, A. (2018) · Repository of the University of Primorsk (University of Primorska)
Substance use and sexual functioning in women: An intricate interplay
Sidana, A. K., & Mahajan, S. (2021) · Indian Journal of Health, Sexuality and Culture
Metadata
- Authors
- Rhodin, A., Stridsberg, M., & Gordh, T.
- Affiliations
- Uppsala University Hospital (SE)
- Corresponding author
- Rhodin, Annica
- Gordh, Torsten
- Venue
- The Clinical Journal of Pain
- Published
- 2010-06
- Volume
- 26
- Issue
- 5
- Pages
- 374-380
- ISSN
- 0749-8047 (ISSN-L)
- OpenAlex
- W2122866774
- Semantic Scholar
- 7f03806c4c29c1464ecc1c49a8b90e6490bbf01d
- Cited by
- 142
- References
- 36
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 6 · 2023: 5 · 2022: 12 · 2021: 15 · 2020: 12 · 2019: 13 · 2018: 11 · 2017: 5 · 2016: 5 · 2015: 10 · 2014: 12 · 2013: 9 · 2012: 9
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Journal of Pain (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- long-term opioid therapy, chronic non-cancer pain, prolactin, hypothalamic-pituitary-gonadal axis, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-thyroid axis, endocrine dysfunction, quality of life, opioid side effects, hormone replacement therapy
- MeSH terms
- Adult, Analgesics, Opioid, Chronic Disease, Drug Administration Schedule, Endocrine System Diseases, Estradiol, Female, Health Status, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Menstrual Cycle, Middle Aged, Pain, Pain Measurement, Pituitary Hormones, Anterior, Pituitary-Adrenal System, Quality of Life, Testosterone, Patient Selection, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.